Further confirmation was recently provided by Ruan and colleagues, who demonstrated that tau oligomers extracted from the cerebral cortex of AD patients strongly inhibited LTP in mouse hippocampal slices and impaired memory in wild-type mice, confirming the ability of such soluble species to induce the typical symptoms of neurodegeneration [195]. Here, MAPT is linked to Alzheimer disease.